How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,145 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Yoga for Chronic Headache in Adolescents

controlled trial to investigate the efficacy of yoga on tension type headache and / or migraine in adolescents between 12 and 16 years, consisting of a four group design which includes an 12 week yoga course and a three-month follow-up period. Both adolescent and one parent will be randomized either to yoga or no treatment. Primary outcome will be pain frequency in adolescents considering pain catastrophizing of parents. Condition or disease Intervention/treatment Phase Tension Type Headache Migraine (...) control The adolescent will receive the intervention after the follow-up period, while one parent will only answer the questionnaires. Outcome Measures Go to Primary Outcome Measures : Pain frequency adolescent [ Time Frame: Week 12 ] Measurement of pain frequency after yoga intervention via headache diary Secondary Outcome Measures : Pain frequency adolescent [ Time Frame: Week 24 ] Measurement of pain frequency after follow-up period via headache diary Pain duration adolescent [ Time Frame: Week 12

2016 Clinical Trials

162. The Association Between Pain Catastrophizing Scale Score and Postspinal Headache

The Association Between Pain Catastrophizing Scale Score and Postspinal Headache The Association Between Pain Catastrophizing Scale Score and Postspinal Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. The Association Between Pain Catastrophizing Scale Score and Postspinal Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02727244 Recruitment Status : Completed First Posted : April 4, 2016 Last Update Posted : June 19, 2018 Sponsor: Tokat Gaziosmanpasa University Information provided

2016 Clinical Trials

163. The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine

. Inclusion Criteria Age 18 to 65 years who present to the ED with complaint of a headache Temperature less than 100.4 F Diastolic blood pressure less than 104 mm Hg Normal neurologic exam and normal mental status Exclusion Criteria Pregnant or breastfeeding Meningeal signs are present Acute angle closure glaucoma is suspected Head trauma within the previous two weeks Lumbar puncture within the previous two weeks Thunderclap (rapid) onset of the headache Weight more than 150 kg or less than 40 kg Known (...) 25 mg IV. Group 2 (research arm) will receive Ketamine 0.3 mg/kg along with ondansetron 4 mg IV. Subjects will be seen at 15, 30, 45, and 60 minutes post-intervention to obtain Heart Rate, Blood Pressure, Headache severity, Nausea severity, Vomiting severity, Anxiety severity, and Restlessness severity. At 24-48 hours post intervention we will contact subjects and assess their pain and assess their satisfaction with their migraine pain management as part of this study. Subjects' participation

2016 Clinical Trials

164. Thoracic Spine Thrust Manipulation for Cervicogenic Headaches: A Randomized Clinical Trial

exercise and instruction to maintain usual activity level within the limits of pain. Other Name: Manual therapy to thoracic spine Outcome Measures Go to Primary Outcome Measures : Headache Disability Index [ Time Frame: Baseline ] Headache Disability Index (HDI): The HDI is a 25-item questionnaire used to assess the patient's perceived impact of the headaches on their daily life. Headache Disability Index [ Time Frame: 4 weeks ] Headache Disability Index (HDI): The HDI is a 25-item questionnaire used (...) or unilateral dominant side-consistent headache associated with neck pain and aggravated by neck postures or movement (Sjaastad et al., 1998) joint tenderness in at least one of the three upper cervical joints (C0-C3) as assessed by manual palpation headache frequency of at least one per week over the past 2 months Exclusion Criteria: red flags noted in the patient's Neck Medical Screening Questionnaire (e.g. tumor, fracture) metabolic diseases RA, osteoporosis, prolonged history of steroid use, symptoms

2016 Clinical Trials

165. Olanzapine for Acute Headaches

trial with the primary aim of comparing how well oral rapidly dissolving olanzapine controls primary headache pain when compared to the current treatment strategies used in emergency departments which often require intravenous or intramuscular medications. Condition or disease Intervention/treatment Phase Headache Drug: Standard of Care as per attending physician Drug: 5mg rapidly dissolving olanzapine Phase 4 Detailed Description: Primary Question: Does oral rapidly dissolving olanzapine provide (...) mg for analgesia in acute primary headaches. Drug: 5mg rapidly dissolving olanzapine 5mg rapidly dissolving olanzapine Other Name: Zydis Outcome Measures Go to Primary Outcome Measures : Change in pain scores based on patient questionnaire [ Time Frame: 30 and 60 minutes post drug ingestion ] relief of primary acute headache Secondary Outcome Measures : Comparison of duration of ED length of stay [ Time Frame: Length of Emergency Department stay (Time Frame: up to 12 hours) ] Comparison

2016 Clinical Trials

166. A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

[ Time Frame: 1 month of baseline recordation followed by 84 days of device use ] reduction in acute, prescribed medications in month 3 of treatment versus baseline month change in headache pain [ Time Frame: 1 month of baseline recordation followed by 84 days of device use ] reduction in subject perceived headache pain scores in month 3 of treatment versus baseline month change in quality of life [ Time Frame: 1 month of baseline recordation followed by 84 days of device use ] comparison of HIT-6 (...) Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: diagnosed with episodic migraine at least 6 months before study at least 3 consecutive months of stable migraine headaches before study at least 4-14 headache days per month, of which 4-14 may be migraines must not have failed on more than 2 classes of migraine preventatives Exclusion Criteria: previous use of the experimental device pregnant using more than 1 concurrent

2016 Clinical Trials

167. Headache Analysis and Intervention

for eligibility information Ages Eligible for Study: 20 Years to 50 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria Headache-group: Males and females between 20 and 50 years Confirmed medical diagnosis of tension-type headache, cervicogenic headache or a mixture Headache can be provoked by awkward cervical and/or head postures Exclusion Criteria Headache-group: Pregnancy History of pericranial surgery Serious pathology (neurological/cardiovascular (...) to be successful in the past (O'Sullivan & Dankaerts, non-specific low back pain). Our study is divided in 2 phases: phase 1: profile analysis (no intervention, experimental headache-group vs. asymptomatic controls) phase 2: interventional phase (clustered headache-groups, based on the results of phase 1 Condition or disease Intervention/treatment Phase Headache Other: Individual Profile Analysis (Physical therapy Intervention) Not Applicable Study Design Go to Layout table for study information Study Type

2016 Clinical Trials

168. Circadian Rhythm and Attack-timing in Episodic Cluster Headache Patients in- and Outside of Bout: an Actigraphic Study

Nunu Lund, Danish Headache Center: Cluster headache actigraphy circadian rhythm Additional relevant MeSH terms: Layout table for MeSH terms Headache Cluster Headache Pain Neurologic Manifestations Signs and Symptoms Trigeminal Autonomic Cephalalgias Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases (...) medication within 2 weeks before the study initiation and during the 2 weeks. Serious somatic and/or psychiatric disorders Alcohol intake > 50 units pr.week Pregnancy / breastfeeding Patient cannot accept the conditions of the trial Patient does not understand Danish. CONTROLS Inclusion Criteria: - Age between 18 and 65 years of age Exclusion Criteria: Circumstances, determined by the PI, that makes the patient ineligible. Any primary headache more than 1 day / month Diagnosed with a secondary headache

2016 Clinical Trials

169. Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT

from Time 0 (baseline) to Time 60 minutes (conclusion of the study for each of the two groups. Rescue Medication [ Time Frame: At the conclusion of the study (60 minutes) ] Comparison between groups for the need for rescue medication as determined by the primary care provider. Follow-up for persistence or recurrence of headache [ Time Frame: 24 -48 hours ] Using a Pain Relief Scale, subjects will be contacted by telephone at 24 - 48 hours after the conclusion of the study and asked to rate (...) their current headache pain. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 65 Years (Adult, Older

2016 Clinical Trials

170. Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache

Last Update Posted: February 2, 2017 Last Verified: February 2017 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Undecided Keywords provided by Nantes University Hospital: Spinal Puncture Dural puncture Nursing Additional relevant MeSH terms: Layout table for MeSH terms Headache Wounds and Injuries Post-Dural Puncture Headache Pain Neurologic Manifestations Signs and Symptoms Headache Disorders, Secondary Headache Disorders Brain Diseases Central Nervous System Diseases (...) Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2016 Clinical Trials

171. A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

sharing agreement. Keywords provided by Eli Lilly and Company: cluster headache headache brain diseases central nervous system diseases headache disorders headache disorders, primary nervous system diseases neurologic manifestations pain trigeminal autonomic cephalalgias Additional relevant MeSH terms: Layout table for MeSH terms Headache Cluster Headache Pain Neurologic Manifestations Signs and Symptoms Trigeminal Autonomic Cephalalgias Headache Disorders, Primary Headache Disorders Brain Diseases (...) A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study

2016 Clinical Trials

172. Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches

Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Precutaneous (...) High Risk Patent Foramen Ovale to Treat Migraine Headaches The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02777359 Recruitment Status : Recruiting First Posted : May 19, 2016 Last Update Posted : July 19, 2017 See

2016 Clinical Trials

173. The Influence of Needle Diameter on Post Dural Puncture Headache

point needle Device: G25 pencil point needle Active Comparator: G27 pencil point needle healthy pregnant women who at (vaginal or cesarean section) delivery get spinal anesthesia administered with use of a 27 gauge pencil point needle Device: G27 pencil point needle Outcome Measures Go to Primary Outcome Measures : number of attempts until successful injection [ Time Frame: 0 (injection time before delivery) ] Secondary Outcome Measures : incidence of post dural puncture headache [ Time Frame: 48 (...) for Study: Female Accepts Healthy Volunteers: No Criteria Inclusion Criteria: healthy pregnant spinal anesthesia at delivery (vaginal delivery or cesarean section emergency grade 2-4) informed consent Exclusion Criteria: chronic headache (attempt to) epidural anesthesia Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer

2016 Clinical Trials

174. Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)

Adult) Sexes Eligible for Study: Female Accepts Healthy Volunteers: No Criteria Inclusion Criteria: All women who received epidural, spinal, or combined spinal-epidural labour analgesia and presenting post-dural puncture headache: Intense: with ≥3 / 10 numerical rating pain scale Appearing within 5 days after delivery Aggravating in sitting or standing position and / or improving supine Can be associated with one of the following criteria: tinnitus, nausea, photophobia, neck stiffness or pain (...) for MeSH terms Headache Wounds and Injuries Post-Dural Puncture Headache Pain Neurologic Manifestations Signs and Symptoms Headache Disorders, Secondary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Cosyntropin Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs

2016 Clinical Trials

175. Self-reported Physical Health of Women Who Did and Did Not Terminate Pregnancy After Seeking Abortion Services: A Cohort Study. (Abstract)

facilities from 2008 to 2010.Of 1132 women seeking abortion who consented to participate, 874 were included in this analysis (328 who had first-trimester abortion, 383 who had second-trimester abortion, and 163 who gave birth).Self-reported overall health; chronic abdominal, pelvic, back, and joint pain; chronic headaches or migraines; obesity; asthma; gestational and nongestational hypertension and diabetes; and hyperlipidemia were assessed semiannually for 5 years. Mortality was assessed by using (...) verbal autopsy and public records.No significant differences were observed in self-rated health or chronic pain after first-trimester versus second-trimester abortion. At 5 years, 27% (95% CI, 21% to 34%) of women who gave birth reported fair or poor health compared with 20% (CI, 16% to 24%) of women who had first-trimester abortion and 21% (CI, 18% to 25%) who had second-trimester abortion. Women who gave birth also reported more chronic headaches or migraines and joint pain, but experienced similar

2019 Annals of Internal Medicine

176. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

, and significant aortic dilatation with underlying connective tissue disease. Women with these conditions are often advised to avoid pregnancy. However, it is not uncommon for women to present pregnant, and at that point, the high-risk cardio-obstetrics team must work together to come up with the best way to mitigate maternal cardiovascular and obstetric risk and fetal risk moving forward. Medical Conditions During Pregnancy Hypertensive Disorders in Pregnancy Hypertensive disorders of pregnancy (HDP (...) treatment before pregnancy. Current treatment options for pregnant women with familial hypercholesterolemia include bile acid sequestrants, which lack systemic circulation, and, as last resort, low-density lipoprotein apheresis in severe cases ( ). , Ischemic Heart Disease in Pregnancy Ischemic heart disease during pregnancy constitutes a rare but potentially fatal condition. The risk of acute myocardial infarction (MI) is 3- to 4-fold higher in pregnant women compared with their nonpregnant

2020 American Heart Association

177. Agreement of self-reported physician diagnosis of migraine with international classification of headache disorders-II migraine diagnostic criteria in a cross-sectional study of pregnant women. Full Text available with Trip Pro

Agreement of self-reported physician diagnosis of migraine with international classification of headache disorders-II migraine diagnostic criteria in a cross-sectional study of pregnant women. Migraine, a common chronic-intermittent disorder among reproductive age women, has emerged as a novel risk factor for adverse perinatal outcomes. Diagnostic reliability of self-report of physician-diagnosed migraine has not been investigated in pregnancy cohort studies. We investigated agreement of self (...) -40 years 10.7%; and >40 years 1.0%). We confirmed self-reported migraine in 81.6% of women when applying the ICHD-II criteria for definitive migraine (63.1%) and probable migraine (18.5%).There is good agreement between self-reported migraine and ICHD-II-based migraine classification in this pregnancy cohort. We demonstrate the feasibility of using questionnaire-based migraine assessment according to full ICHD-II criteria in epidemiological studies of pregnant women.

2013 BMC Women's Health

178. Allergic rhinitis during pregnancy: opt for the lowest risk

, including in women who are or could be pregnant (local irritations, headaches in particular). It is the topical treatment of choice for mild allergic rhinitis in pregnant women. Nasal antihistamines, especially preservative-free azelastine, have not been linked to any particular risk during pregnancy. Oral non-sedating and non-antimuscarinic antihistamines are an alternative to topical treatments when the allergic rhinitis is troublesome: cetirizine is an acceptable option throughout pregnancy (...) for the lowest risk When drug treatment for allergic rhinitis is recommended in a pregnant woman, there are various options that expose the patient to few risks: sodium cromoglicate or azelastine nasal inhaler or an oral or nasal non-sedating and non-antimuscarinic antihistamine. Allergic rhinitis is a benign allergic reaction. Sometimes causing extreme discomfort, it has no known effect on pregnancy outcome. Sodium cromoglicate nasal spray is moderately effective, but can have rare adverse effects

2016 Prescrire

179. The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum

settings. It gives advice for multidisciplinary professionals involved in the care of women with these conditions, including how to counsel and support women before, during and after their pregnancies. 2. Introduction and background epidemiology NVP affects up to 80% of pregnant women 1 and is one of the most common indications for hospital admission among pregnant women, with typical stays of between 3 and 4 days. 2–4 For this guideline, NVP is defined as the symptom of nausea and/or vomiting during (...) early pregnancy where there are no other causes. HG is the severe form of NVP , which affects about 0.3–3.6% of pregnant women. 1,5–7 Reported HG recurrence rates vary, from 15.2% in a Norwegian hospital registry study 8 to 81% if using self-reported diagnosis. 9 © Royal College of Obstetricians and Gynaecologists 5 of 27 RCOG Green-top Guideline No. 69 P C D C C C D D DThe aetiological theories for NVP and HG range from the fetoprotective and genetic to the biochemical, immunological and biosocial

2016 Royal College of Obstetricians and Gynaecologists

180. Epilepsy in Pregnancy

with epilepsy (WWE), their families and healthcare professionals should be aware of the different types of epilepsy and their presentation to assess the specific risks to the mother and baby. What other conditions in pregnancy should be considered in the differential diagnosis of epileptic seizures? In pregnant women presenting with seizures in the second half of pregnancy which cannot be clearly attributed to epilepsy, immediate treatment should follow existing protocols for eclampsia management until (...) a definitive diagnosis is made by a full neurological assessment. Other cardiac, metabolic and intracranial conditions should be considered in the differential diagnosis. Neuropsychiatric conditions including non-epileptic attack disorder should also be considered. Prepregnancy counselling and management What are the risks of congenital malformations in the fetus of pregnant women with epilepsy (WWE) exposed and not exposed to antiepileptic drugs (AEDs)? WWE who are planning their pregnancy should have

2016 Royal College of Obstetricians and Gynaecologists

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>